Metformin Plus Sorafenib for Advanced HCC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02672488

Recruitment Status : Unknown

Verified December 2015 by Tianjin Medical University Cancer Institute and Hospital.
Recruitment status was: Recruiting

First Posted : February 3, 2016

Last Update Posted : February 3, 2016

Sponsor:

Collaborators:

First Affiliated Hospital of Harbin Medical University

Harbin Medical University

Liaoning Tumor Hospital & Institute

Shanghai Zhongshan Hospital

Fudan University

Information provided by (Responsible Party):

Tianjin Medical University Cancer Institute and Hospital

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	December 2017
Estimated Study Completion Date :	December 2018

To Top